Skip to content

ELOXX PHARMACEUTICALS, INC.: 10-K/A filed 2012-10-26

What ELOXX PHARMACEUTICALS, INC. reported in its annual report amendment filed 2012-10-26 (fiscal FY 2012): 31 published measures, 114 facts as tagged in accession 0001144204-12-057875.

This is an amendment. Values here are as tagged in the amendment; the original filing has its own page.

This filing

Form
10-K/A (annual report amendment)
Filed
2012-10-26
Fiscal period
fiscal FY 2012
Accession
0001144204-12-057875 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ELOXX PHARMACEUTICALS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2012-06-306,954,869USD
At 2011-06-308,596,889USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2012-06-303,501,841USD
At 2011-06-304,079,426USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2012-06-303,453,028USD
At 2011-06-304,517,463USD
At 2010-06-307,981,024USD
At 2009-06-305,667,834USD
At 2008-06-309,835,679USD
At 2007-06-302,689,539USD
At 2006-06-302,951,966USD
At 2005-06-305,589,751USD
At 2004-06-304,730,975USD
At 2003-06-302,856,514USD
At 2002-06-304,785,676USD
At 2001-06-30-206,713USD
At 2000-06-301,518,558USD
At 1999-06-30912,166USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2012-06-302,001,325USD
At 2011-06-303,609,954USD
At 2010-06-308,026,296USD
At 2009-06-30380,569USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2011-07-01 to 2012-06-30-5,066,133USD366
1998-07-01 to 2012-06-30-56,936,754USD5114
2010-07-01 to 2011-06-30-7,268,976USD365
2009-07-01 to 2010-06-30-13,383,513USD365
2008-07-01 to 2009-06-30-5,726,869USD365
2007-07-01 to 2008-06-30-4,601,490USD366
2006-07-01 to 2007-06-30-3,251,697USD365
2005-07-01 to 2006-06-30-3,314,885USD365
2004-07-01 to 2005-06-30-2,978,918USD365
2003-07-01 to 2004-06-30-3,726,951USD366
2002-07-01 to 2003-06-30-2,778,004USD365
2001-07-01 to 2002-06-30-3,021,709USD365
2000-07-01 to 2001-06-30-2,033,890USD365
1999-07-01 to 2000-06-30-3,346,491USD366
1998-07-01 to 1999-06-30-1,168,995USD365

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2011-07-01 to 2012-06-30-4,386,049USD366
1998-07-01 to 2012-06-30-37,022,390USD5114
2010-07-01 to 2011-06-30-5,391,442USD365
2009-07-01 to 2010-06-30-4,743,129USD365

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2011-07-01 to 2012-06-304,461USD366
1998-07-01 to 2012-06-30184,666USD5114
2010-07-01 to 2011-06-302,026USD365
2009-07-01 to 2010-06-301,116USD365

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2011-07-01 to 2012-06-30200,000USD366
1998-07-01 to 2012-06-301,790,000USD5114
2009-07-01 to 2010-06-30140,000USD365

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2011-07-01 to 2012-06-303,227,916USD366
1998-07-01 to 2012-06-3045,433,093USD5114
2010-07-01 to 2011-06-301,661,525USD365
2009-07-01 to 2010-06-3012,147,887USD365

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2011-07-01 to 2012-06-30-450,496USD366
1998-07-01 to 2012-06-30-6,409,378USD5114
2010-07-01 to 2011-06-30-686,425USD365
2009-07-01 to 2010-06-30240,969USD365

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2012-06-305,857USD
At 2011-06-303,782USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2011-07-01 to 2012-06-30766,004USD366
1998-07-01 to 2012-06-3012,105,953USD5114
2010-07-01 to 2011-06-30750,366USD365
2009-07-01 to 2010-06-30386,639USD365

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2011-07-01 to 2012-06-30-5,090,391USD366
1998-07-01 to 2012-06-30-51,060,282USD5114
2010-07-01 to 2011-06-30-6,330,616USD365
2009-07-01 to 2010-06-30-4,846,523USD365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2012-06-303,549,849USD
At 2011-06-305,056,018USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2012-06-303,163,317USD
At 2011-06-303,268,439USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2012-06-30594,514USD
At 2011-06-30559,525USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2012-06-303,393,992USD
At 2011-06-303,524,731USD

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2011-07-01 to 2012-06-302,566,247USD366
1998-07-01 to 2012-06-3021,235,605USD5114
2010-07-01 to 2011-06-303,720,394USD365
2009-07-01 to 2010-06-302,637,407USD365

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2012-06-3094,112,483shares
At 2011-06-3077,769,677shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2012-06-3069,952,152USD
At 2011-06-3064,488,152USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2012-06-3098,727USD
At 2011-06-3094,266USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2012-06-3092,870USD
At 2011-06-3090,484USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2012-06-303,393,992USD
At 2011-06-303,524,731USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2012-06-3099,728USD
At 2011-06-3099,728USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2012-06-30369,695USD
At 2011-06-30509,806USD

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2011-07-01 to 2012-06-30-6,691,860USD366
1998-07-01 to 2012-06-30-67,440,295USD5114
2010-07-01 to 2011-06-30-9,907,276USD365
2009-07-01 to 2010-06-30-19,623,027USD365

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2011-07-01 to 2012-06-302,724,144USD366
1998-07-01 to 2012-06-3031,614,677USD5114
2010-07-01 to 2011-06-302,610,222USD365
2009-07-01 to 2010-06-302,349,116USD365

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2011-07-01 to 2012-06-302,386USD366
1998-07-01 to 2012-06-30178,809USD5114
2010-07-01 to 2011-06-302,798USD365
2009-07-01 to 2010-06-302,548USD365

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2011-07-01 to 2012-06-30255,637USD366
1998-07-01 to 2012-06-30921,496USD5114
2010-07-01 to 2011-06-30140,476USD365
2009-07-01 to 2010-06-30124,019USD365

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
1998-07-01 to 2012-06-30205,390USD5114
2010-07-01 to 2011-06-30-115,869USD365

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2011-07-01 to 2012-06-3034,989USD366
1998-07-01 to 2012-06-30594,514USD5114
2010-07-01 to 2011-06-302,105USD365
2009-07-01 to 2010-06-30-419,260USD365

Inspect the source

Entity
ELOXX PHARMACEUTICALS, INC. / CIK 0001035354
Captured
2026-09-20T05:15:09.498Z
SEC response SHA-256
b351a9ed06ee3e6f1d738bbdb3852b866526fe561e11a7ffd4a81bc43bb27195

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001035354.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))